-
Notifications
You must be signed in to change notification settings - Fork 30
/
scopus.ris
1956 lines (1930 loc) · 175 KB
/
scopus.ris
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
TI - Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)
T2 - Journal of the American Medical Association
VL - 285
IS - 19
SP - 2486
EP - 2497
PY - 2001
AU - Cleeman J.I.
N1 - Export Date: 3 January 2016
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-0035897696&partnerID=40&md5=cf5b8dd2606377aad2a8b7a9be81f971
ER -
TI - PLINK: A tool set for whole-genome association and population-based linkage analyses
T2 - American Journal of Human Genetics
VL - 81
IS - 3
SP - 559
EP - 575
PY - 2007
AU - Purcell S.
AU - Neale B.
AU - Todd-Brown K.
AU - Thomas L.
AU - Ferreira M.A.R.
AU - Bender D.
AU - Maller J.
AU - Sklar P.
AU - De Bakker P.I.W.
AU - Daly M.J.
AU - Sham P.C.
N1 - Export Date: 3 January 2016
N1 - References: Haploview, , http://www.broad.mit.edu/mpg/haploview;
HapMap, , http://www.hapmap.org;
PLINK and gPLINK, , http://pngu.mgh.harvard.edu/purcell/plink;
Queue portal, , https://queue.coriell.org/q, at the Coriell Institute;
Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265:2037-2048 (erratum 266:353)Risch N., Merikangas K., The future of genetic studies of complex human diseases (1996) Science, 273, pp. 1516-1517;
Hirschhorn J.N., Lohmueller K., Byrne E., Hirschhorn K., A comprehensive review of genetic association studies (2002) Genet Med, 4, pp. 45-61;
Ioannidis J.P., Trikalinos T.A., Khoury M.J., Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases (2006) Am J Epidemiol, 164, pp. 609-614;
Reich D.E., Lander E.S., On the allelic spectrum of human disease (2001) Trends Genet, 17, pp. 502-510;
Freedman M.L., Reich D., Penney K.L., McDonald G.J., Mignault A.A., Patterson N., Gabriel S.B., Pato C.N., Assessing the impact of population stratification on genetic association studies (2004) Nat Genet, 36, pp. 388-393;
Devlin B., Roeder K., Genomic control for association studies (1999) Biometrics, 55, pp. 997-1004;
Pritchard J.K., Stephens M., Donnelly P.J., Inference of population structure using multilocus genotype data (2000) Genetics, 155, pp. 945-959;
Purcell S., Sham P.C., Properties of structured association approaches to detecting population stratification (2004) Hum Hered, 58, pp. 93-107;
Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D., Principal components analysis corrects for stratification in genome-wide association studies (2006) Nat Genet, 38, pp. 904-909;
Clayton D.G., Walker N.M., Smyth D.J., Pask R., Cooper J.D., Maier L.M., Smink L.J., Stevens H.E., Population structure, differential bias and genomic control in a large-scale, case-control association study (2005) Nat Genet, 37, pp. 1243-1246;
Hirschhorn J.N., Daly M.J., Genome-wide association studies for common diseases and complex traits (2005) Nat Rev Genet, 6, pp. 95-108;
Pritchard J.K., Are rare variants responsible for susceptibility to complex diseases? (2001) Am J Hum Genet, 69, pp. 124-137;
Houwen R.H., Baharloo S., Blankenship K., Raeymaekers P., Juyn J., Sandkuijl L.A., Freimer N.B., Genome screening by searching for shared segments: Mapping a gene for benign recurrent intrahepatic cholestasis (1994) Nat Genet, 8, pp. 380-386;
te Meerman G.J., van der Meulen M.A., Sandkuijl L.A., Perspectives of identity by descent (IBD) mapping in founder populations (1995) Clin Exp Allergy, 25, pp. 97-102;
Wigginton J.E., Cutler D.J., Abecasis G.R., A note on exact tests of Hardy-Weinberg equilibrium (2005) Am J Hum Genet, 76, pp. 887-893;
Lee W.C., Detecting population stratification using a panel of SNPs (2003) Int J Epidemiol, 32, p. 1120;
Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes for BioMedical Research (2007) Genome-wide association analysis identifies novel loci for type 2 diabetes and triglyceride levels. Science 316:1331-1336Agresti A., (1990) Categorical data analysis, pp. 100-102. , John Wiley, New York, pp;
Fleiss J.L., (1981) Statistical methods for rates and proportions, , 2nd ed. Wiley, New York;
Ewens W.J., Spielman R.S., The transmission/disequilibrium test: History, subdivision, and admixture (1995) Am J Hum Genet, 57, pp. 455-465;
Spielman R.S., Ewens W.J., A sibship test for linkage in the presence of association: The sib transmission/disequilibrium test (1998) Am J Hum Genet, 62, pp. 450-458;
Fulker D.W., Cherny S.S., Sham P.C., Hewitt J.K., Combined linkage and association sib-pair analysis for quantitative traits (1999) Am J Hum Genet, 64, pp. 259-267;
Abecasis G.R., Cardon L.R., Cookson W.O., A general test of association for quantitative traits in nuclear families (2000) Am J Hum Genet, 66, pp. 279-292;
Purcell S., Sham P.C., Daly M.J., Parental phenotypes in family-based association analysis (2005) Am J Hum Genet, 76, pp. 249-259;
Ferreira M.A.R., Sham P.C., Daly M.J., Purcell S., Ascertainment through family history of disease often decreases the power of family-based association studies (2007) Behav Genet, 37, pp. 631-636
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-34548292504&partnerID=40&md5=144c434ad3c0e91e814a9cf4d73e0c43
ER -
TI - The metabolic syndrome - A new worldwide definition
T2 - Lancet
VL - 366
IS - 9491
SP - 1059
EP - 1062
PY - 2005
AU - Alberti K.G.M.M.
AU - Zimmet P.
AU - Shaw J.
N1 - Export Date: 3 January 2016
N1 - References: Eckel R.H., Grundy S.M., Zimmet P.Z., The metabolic syndrome (2005) Lancet, 365, pp. 1415-1428;
Kylin E., Studien ueber das Hypertonie-Hyperglyka "mie-Hyperurika" miesyndrom (1923) Zentralblatt fuer Innere Medizin, 44, pp. 105-127;
Reaven G., Role of insulin resistance in human disease (1988) Diabetes, 37, pp. 1595-1607;
Lemieux I., Pascot A., Couillard C., Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; Hyperapolipoprotein B; Small, dense LDL) in men? (2000) Circulation, 102, pp. 179-184;
Alberti K., Zimmet P., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation (1998) Diabet Med, 15, pp. 539-553;
Balkau B., Charles M.A., Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) (1999) Diabet Med, 16, pp. 442-443;
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) JAMA, 285, pp. 2486-2497;
Cameron A.J., Shaw J.E., Zimmet P.Z., The metabolic syndrome: Prevalence in worldwide populations (2004) Endocrinol Metab Clin North Am, 33, pp. 351-376;
Stern M.P., Williams K., Gonzalez-Villalpando C., Hunt K.J., Haffner S.M., Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? (2004) Diabetes Care, 27, pp. 2676-2681;
Lakka H.M., Laaksonen D.E., Lakka T.A., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men (2002) JAMA, 288, pp. 2709-2716;
WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies (2004) Lancet, 363, pp. 157-163;
Tan C.E., Ma S., Wai D., Chew S.K., Tai E.S., Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? (2004) Diabetes Care, 27, pp. 1182-1186;
Diabetes Federation I., (2005) The IDF Consensus Worldwide Definition of the Metabolic Syndrome, , http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf;
Snehalatha C., Viswanathan V., Ramachandran A., Cutoff values for normal anthropometric variables in asian Indian adults (2003) Diabetes Care, 26, pp. 1380-1384;
New criteria for 'obesity disease' in Japan (2002) Circ J, 66, pp. 987-992;
Genuth S., Alberti K.G., Bennett P., Follow-up report on the diagnosis of diabetes mellitus (2003) Diabetes Care, 26, pp. 3160-3167;
Lindstrom J., Louheranta A., Mannelin M., The Finnish Diabetes Prevention Study Group F., The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity (2003) Diabetes Care, 26, pp. 3230-3236;
Van Gaal L.F., Rissanen A.M., Scheen A.J., Rio-Europe Study Group T., Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study (2005) Lancet, 365, pp. 1389-1397;
Kahn R., Buse J., Ferrannini E., Stern M., The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes (2005) Diabetes Care, 28, pp. 2289-2304. , [AlsoDiabetologia2005;publishedonlineAug4.DOI:10.1007/s00125-005-1876-2];
Zimmet P., Shaw J., Alberti K.G., Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: A realistic view (2003) Diabet Med, 20, pp. 693-702;
Gale E.A.M., Editorial: The myth of the metabolic syndrome (2005) Diabetologia, 10, pp. 1873-1875
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-25144459980&partnerID=40&md5=38bd96cc472397a827dba6d43ecb22f8
ER -
TI - A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity
T2 - Science
VL - 316
IS - 5826
SP - 889
EP - 894
PY - 2007
AU - Frayling T.M.
AU - Timpson N.J.
AU - Weedon M.N.
AU - Zeggini E.
AU - Freathy R.M.
AU - Lindgren C.M.
AU - Perry J.R.B.
AU - Elliott K.S.
AU - Lango H.
AU - Rayner N.W.
AU - Shields B.
AU - Harries L.W.
AU - Barrett J.C.
AU - Ellard S.
AU - Groves C.J.
AU - Knight B.
AU - Patch A.-M.
AU - Ness A.R.
AU - Ebrahim S.
AU - Lawlor D.A.
AU - Ring S.M.
AU - Ben-Shlomo Y.
AU - Jarvelin M.-R.
AU - Sovio U.
AU - Bennett A.J.
AU - Melzer D.
AU - Ferrucci L.
AU - Loos R.J.F.
AU - Barroso I.
AU - Wareham N.J.
AU - Karpe F.
AU - Owen K.R.
AU - Cardon L.R.
AU - Walker M.
AU - Hitman G.A.
AU - Palmer C.N.A.
AU - Doney A.S.F.
AU - Morris A.D.
AU - Smith G.D.
AU - Hattersley A.T.
AU - McCarthy M.I.
N1 - Export Date: 3 January 2016
N1 - References: Ogden C.L., et. al., (2006) JAMA, 295, p. 1549;
Maes H.H.M., Neale M.C., Eaves L.J., (1997) Behav. Genet, 27, p. 325;
I. S. Farooqi, S. O'Rahilly, Endocr. Rev. 10.1210/er.2006-0040 (2006)Boutin P., (2003) PLoS Biol, 1, p. 361;
Meyre D., (2005) Nat. Genet, 37, p. 863;
Swarbrick M.M., (2005) PLoS Biol, 3, p. 1662;
Groves C.J., (2006) Diabetes, 55, p. 1884;
Weedon M.N., (2006) Diabetes, 55, p. 3175;
Herbert A., (2006) Science, 312, p. 279;
Loos R.J.F., Barroso I., O'Rahilly S., Wareham N.J., (2007) Science, 315, pp. 179c;
Rosskopf D., (2007) Science, 315, pp. 179d;
Dina C., (2007) Science, 315, pp. 179b;
Materials and methods are available as supporting material on Science OnlineHiggins J.P., Thompson S.G., Deeks J.J., Altman D.G., (2003) BMJ, 327, p. 557;
Lobstein T., Baur L., Uauy R., (2004) Obes. Rev, 5, p. 4;
Zhang S., Zhu X., Zhao H., (2003) Genet. Epidemiol, 24, p. 44;
Price A.L., (2006) Nat. Genet, 38, p. 904;
Peters T., Ausmeier K., Dildrop R., Rüther U., (2002) Mamm. Genome, 13, p. 186;
van der Hoeven F., (1994) Development, 120, p. 2601;
Collection of the type 2 diabetes cases was supported by Diabetes UK, British Diabetic Association Research, and the UK Medical Research Council (Biomedical Collections Strategic Grant G0000649, The UK Type 2 Diabetes Genetics Consortium collection was supported by the Wellcome Trust (Biomedical Collections Grant GR072960, The ALSPAC study was supported by the UK Medical Research Council (MRC, the Wellcome Trust, and the University of Bristol. The British Women's Heart and Health Study was funded by the Department of Health and the British Heart Foundation. The Caerphilly study was funded by MRC and the British Heart Foundation. The Caerphilly study was undertaken by the former MRC Epidemiology Unit (South Wales) and was funded by the MRC. The data archive is maintained by the Department of Social Medicine, University of Bristol. The Exeter Family Study of Childhood Health was supported by NHS Research and Development and the Wellcome Trust. The work on the Northern Finland birth coUR - http://www.scopus.com/inward/record.url?eid=2-s2.0-34248594090&partnerID=40&md5=d4fa0b32e7e761c68e5ecf809c576c65
ER -
TI - A genome-wide association study identifies novel risk loci for type 2 diabetes
T2 - Nature
VL - 445
IS - 7130
SP - 881
EP - 885
PY - 2007
AU - Sladek R.
AU - Rocheleau G.
AU - Rung J.
AU - Dina C.
AU - Shen L.
AU - Serre D.
AU - Boutin P.
AU - Vincent D.
AU - Belisle A.
AU - Hadjadj S.
AU - Balkau B.
AU - Heude B.
AU - Charpentier G.
AU - Hudson T.J.
AU - Montpetit A.
AU - Pshezhetsky A.V.
AU - Prentki M.
AU - Posner B.I.
AU - Balding D.J.
AU - Meyre D.
AU - Polychronakos C.
AU - Froguel P.
N1 - Export Date: 3 January 2016
N1 - References: Permutt M.A., Wasson J., Cox N., Genetic epidemiology of diabetes (2005) J. Clin. Invest, 115, pp. 1431-1439;
Horikawa Y., Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus (2000) Nature Genet, 26, pp. 163-175;
Meyre D., Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes (2005) Nature Genet, 37, pp. 863-867;
Love-Gregory L.D., A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4α gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population (2004) Diabetes, 53, pp. 1134-1140;
Silander K., Genetic variation near the hepatocyte nuclear factor-4α gene predicts susceptibility to type 2 diabetes (2004) Diabetes, 53, pp. 1141-1149;
Vasseur F., Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians (2002) Hum. Mol. Genet, 11, pp. 2607-2614;
Altshuler D., The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes (2000) Nature Genet, 26, pp. 76-80;
Gloyn A.L., Large-scale association studies of variants in genes encoding the pancreatic β-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes (2003) Diabetes, 52, pp. 568-572;
Grant S.F., Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes (2006) Nature Genet, 38, pp. 320-323;
Zhang C., Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men (2006) Diabetes, 55, pp. 2645-2648;
Damcott C.M., Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: Replication and evidence for a role in both insulin secretion and insulin resistance (2006) Diabetes, 55, pp. 2654-2659;
Scott L.J., Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample (2006) Diabetes, 55, pp. 2649-2653;
Groves C.J., Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk (2006) Diabetes, 55, pp. 2640-2644;
Cauchi S., TCF7L2 variation predicts hyperglycemia incidence in a French general population: The data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study (2006) Diabetes, 55, pp. 3189-3192;
Chandak G.R., Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population (2007) Diabetologia, 50, pp. 63-67;
Florez J.C., TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program (2006) N. Engl. J. Med, 355, pp. 241-250;
Humphries S.E., Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European whites, Indian Asians and Afro-Caribbean men and women (2006) J. Mol. Med, 84, pp. 1-10;
Parton L.E., Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: A functional and gene profiling analysis (2006) Am. J. Physiol. Endocrinol. Metab, 291, pp. E982-E994;
Saxena R., Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals (2006) Diabetes, 55, pp. 2890-2895;
Weedon M.N., Combining information from common type 2 diabetes risk polymorphisms improves disease prediction (2006) PLoS Med, 3, pp. e374;
Fingerlin T.E., Boehnke M., Abecasis G.R., Increasing the power and efficiency of disease-marker case-control association studies through use of allele-sharing information (2004) Am. J. Hum. Genet, 74, pp. 432-443;
Balkau B., An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): Epidemiologic data on the insulin resistance syndrome (1996) Rev. Epidemiol. Sante Publique, 44, pp. 373-375;
A haplotype map of the human genome (2005) Nature, 437, pp. 1299-1320. , International HapMap Consortium;
Campbell C.D., Demonstrating stratification in a European American population (2005) Nature Genet, 37, pp. 868-872;
Chimienti F., In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion (2006) J. Cell Sci, 119, pp. 4199-4206;
Duggirala R., Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans (1999) Am. J. Hum. Genet, 64, pp. 1127-1140;
Ghosh S., The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes (2000) Am. J. Hum. Genet, 67, pp. 1174-1185;
Meigs, J. B., Panhuysen, C. I., Myers, R. H., Wilson, P. W. & Cupples, L. A. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes 51, 833-840 (2002)Wiltshire S., A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): Analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q (2001) Am. J. Hum. Genet, 69, pp. 553-569;
Bort R., Martinez-Barbera J.P., Beddington R.S., Zaret K.S., Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas (2004) Development, 131, pp. 797-806;
Bort R., Signore M., Tremblay K., Martinez Barbera J.P., Zaret K.S., Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development (2006) Dev. Biol, 290, pp. 44-56;
Foley A.C., Mercola M., Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex (2005) Genes Dev, 19, pp. 387-396;
Bennett R.G., Hamel F.G., Duckworth W.C., An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures (2003) Diabetes, 52, pp. 2315-2320;
Farris W., Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo (2003) Proc. Natl Acad. Sci. USA, 100, pp. 4162-4167;
Groves C.J., Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility (2003) Diabetes, 52, pp. 1300-1305;
Karamohamed S., Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study (2003) Diabetes, 52, pp. 1562-1567;
Florez J.C., High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people (2006) Diabetes, 55, pp. 128-135;
Apelqvist A., Ahlgren U., Edlund H., Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas (1997) Curr. Biol, 7, pp. 801-804;
Thomas M.K., Rastalsky N., Lee J.H., Habener J.F., Hedgehog signaling regulation of insulin production by pancreatic β-cells (2000) Diabetes, 49, pp. 2039-2047;
Boras-Granic K., Grosschedl R., Hamel P.A., Genetic interaction between Lef1 and Alx4 is required for early embryonic development (2006) Int. J. Dev. Biol, 50, pp. 601-610;
Di Rienzo A., Hudson R.R., An evolutionary framework for common diseases: The ancestral-susceptibility model (2005) Trends Genet, 21, pp. 596-601;
Pritchard J.K., Are rare variants responsible for susceptibility to complex diseases? (2001) Am. J. Hum. Genet, 69, pp. 124-137;
Hallaq H., A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels (2004) Development, 131, pp. 5197-5209;
Stickens D., The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes (1996) Nature Genet, 14, pp. 25-32;
Pritchard J.K., Stephens M., Donnelly P., Inference of population structure using multilocus genotype data (2000) Genetics, 155, pp. 945-959;
Sasieni P.D., From genotypes to genes: Doubling the sample size (1997) Biometrics, 53, pp. 1253-1261;
Clayton D.G., Population structure, differential bias and genomic control in a large-scale, case-control association study (2005) Nature Genet, 37, pp. 1243-1246;
Devlin B., Roeder K., Genomic control for association studies (1999) Biometrics, 55, pp. 997-1004;
Reich D.E., Goldstein D.B., Detecting association in a case-control study while correcting for population stratification (2001) Genet. Epidemiol, 20, pp. 4-16;
Kohler K., Bickeboller H., Case-control association tests correcting for population stratification (2006) Ann. Hum. Genet, 70, pp. 98-115
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-33847176604&partnerID=40&md5=9d8966d58a568fe77986e393ba1973ab
ER -
TI - Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
T2 - Science
VL - 316
IS - 5829
SP - 1331
EP - 1336
PY - 2007
AU - Saxena R.
AU - Voight B.F.
AU - Lyssenko V.
AU - Burtt N.P.
AU - De Bakker P.I.W.
AU - Chen H.
AU - Roix J.J.
AU - Kathiresan S.
AU - Hirschhorn J.N.
AU - Daly M.J.
AU - Hughes T.E.
AU - Groop L.
AU - Altshuler D.
N1 - Export Date: 3 January 2016
N1 - References: Fisher R.A., (1918) Trans. R. Soc. Edinb, 52, p. 399;
Kimura M., Ota T., (1973) Genetics, 75, p. 199;
(2005) Nature, 437, p. 1299. , The International Haplotype Map Consortium;
Materials and methods are available as supporting material on Science OnlinePe'er I., (2006) Nat. Genet, 38, p. 663;
de Bakker P.-I.W., (2005) Nat. Genet, 37, p. 1217;
Campbell C.D., (2005) Nat. Genet, 37, p. 868;
Clayton D.G., (2005) Nat. Genet, 37, p. 1243;
Price A.L., (2006) Nat. Genet, 38, p. 904;
Nature, , The Wellcome Trust Case Control Consortium, in press;
Scott L.J., (2007) Science, 316, p. 1341;
Zeggini E., (2007) Science, 316, p. 1336;
Krishnamurthy J., (2006) Nature, 443, p. 453;
Nielsen F.C., Nielsen J., Christiansen J., (2001) Scand. J. Clin. Lab. Invest. Suppl, 234, p. 93;
Spagnoli F.M., Brivanlou A.H., (2006) Dev. Biol, 292, p. 442;
Wagner M., (2003) Gastroenterology, 124, p. 1901;
Ubeda M., Rukstalis J.M., Habener J.F., (2006) J. Biol. Chem, 281, p. 28858;
Grant S.F., (2006) Nat. Genet, 38, p. 320;
Sladek R., (2007) Nature, 445, p. 881;
Hani E.H., (1998) Diabetologia, 41, p. 1511;
Deeb S.S., (1998) Nat. Genet, 20, p. 284;
Slosberg E.D., (2001) Diabetes, 50, p. 1813;
O'Doherty R.M., Lehman D.L., Telemaque-Potts S., Newgard C.B., (1999) Diabetes, 48, p. 2022;
Ferre T., Riu E., Bosch F., Valera A., (1996) FASEB J, 10, p. 1213;
Graham R.R., (2007) Proc. Natl. Acad. Sci. U.S.A, 104, p. 6758;
Maller J., (2006) Nat. Genet, 38, p. 1055;
Li M., (2006) Nat. Genet, 38, p. 1049;
Duerr R.H., (2006) Science, 314, p. 1461;
Hugot J.P., (2001) Nature, 411, p. 599;
Halman C.A., (2007) Nat. Genet, 39, p. 638;
Kotowski I.K., (2006) Am. J. Hum. Genet, 78, p. 410;
We are indebted to all participants in the studies for their support and contributions. This work was supported by Novartis Institutes for BioMedical Research (D.A, with additional support from The Richard and Susan Smith Family Foundation/American Diabetes Association Pinnacle Program Project Award (D.A, J.N.H, M.J.D, We thank our colleagues from the UKT2D study and the FUSION study for sharing data before publication and for close and enjoyable collaboration. We thank P. Donnelly for sharing results before publication on behalf of the WTCCC. The following are supported by NIH Research Career Awards: J.C.F, K23 DK65978-04, H.N.L, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) K23 DK067288, NIH Research Service Award (R.S, and a NIH Training grant award (E.K.S, G.L. is supported by March of Dimes research grant (6-FY04-61, S.K.'s work is supported by grants from the Doris Duke Charitable Foundation, the Fannie E. Rippel Foundation, and NIH granUR - http://www.scopus.com/inward/record.url?eid=2-s2.0-34249888775&partnerID=40&md5=f11025802b7a97277582dede63f179d9
ER -
TI - A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants
T2 - Science
VL - 316
IS - 5829
SP - 1341
EP - 1345
PY - 2007
AU - Scott L.J.
AU - Mohlke K.L.
AU - Bonnycastle L.L.
AU - Willer C.J.
AU - Li Y.
AU - Duren W.L.
AU - Erdos M.R.
AU - Stringham H.M.
AU - Chines P.S.
AU - Jackson A.U.
AU - Prokunina-Olsson L.
AU - Ding C.-J.
AU - Swift A.J.
AU - Narisu
AU - Hu T.
AU - Pruim R.
AU - Xiao R.
AU - Li X.-Y.
AU - Conneely K.N.
AU - Riebow N.L.
AU - Sprau A.G.
AU - Tong M.
AU - White P.P.
AU - Hetrick K.N.
AU - Barnhart M.W.
AU - Bark C.W.
AU - Goldstein J.L.
AU - Watkins L.
AU - Xiang F.
AU - Saramies J.
AU - Buchanan T.A.
AU - Watanabe R.M.
AU - Valle T.T.
AU - Kinnunen L.
AU - Abecasis G.R.
AU - Pugh E.W.
AU - Doheny K.F.
AU - Bergman R.N.
AU - Tuomilehto J.
AU - Collins F.S.
AU - Boehnke M.
N1 - Export Date: 3 January 2016
N1 - References: Wild S., Roglic G., Green A., Sicree R., King H., (2004) Diabetes Care, 27, p. 1047;
Rich S.S., (1990) Diabetes, 39, p. 1315;
Kaprio J., (1992) Diabetologia, 35, p. 1060;
Diabetes Genetics Initiative, Science 316, 1331 (2007); published online 26 April 2007 (10.1126/science.1142358)E. Zeggini et al., Science 316, 1336 (2007); published online 26 April 2007 (10.1126/science.1142364)Nature, , The Wellcome Trust Case Control Consortium, in press;
Sladek R., (2007) Nature, 445, p. 881;
Materials and methods are available as supporting material on Science OnlineValle T., (1998) Diabetes Care, 21, p. 949;
Silander K., (2004) Diabetes, 53, p. 821;
Saaristo T., Diabetes Vasc. Dis. Res (2005), 2, p. 67Devlin B., Roeder K., (1999) Biometrics, 55, p. 997;
Y. Li, P. Scheet, J. Ding, G. R. Abecasis, submitted for publication; manuscript available from G.R.A. (e-mail: [email protected])(2005) Nature, 437, p. 1299. , International HapMap Consortium;
Grant S.F., (2006) Nat. Genet, 38, p. 320;
Deeb S.S., (1998) Nat. Genet, 20, p. 284;
Altshuler D., (2000) Nat. Genet, 26, p. 76;
Gloyn A.L., (2003) Diabetes, 52, p. 568;
Nielsen J., (1999) Mol. Cell. Biol, 19, p. 1262;
Chimienti F., Devergnas S., Favier A., Seve M., (2004) Diabetes, 53, p. 2330;
Chimienti F., (2006) J. Cell Sci, 119, p. 4199;
Dunn M.F., (2005) Biometals, 18, p. 295;
Ching Y.P., Pang A.S., Lam W.H., Qi R.Z., Wang J.H., (2002) J. Biol. Chem, 277, p. 15237;
Ubeda M., Kemp D.M., Habener J.F., (2004) Endocrinology, 145, p. 3023;
Wei F.Y., (2005) Nat. Med, 11, p. 1104;
Ubeda M., Rukstalis J.M., Habener J.F., (2006) J. Biol. Chem, 281, p. 28858;
Rane S.G., (1999) Nat. Genet, 22, p. 44;
Tsutsui T., (1999) Mol. Cell. Biol, 19, p. 7011;
Kim W.Y., Sharpless N.E., (2006) Cell, 127, p. 265;
Bort R., Martinez-Barbera J.P., Beddington R.S., Zaret K.S., (2004) Development, 131, p. 797;
T. M. Frayling et al., Science 316, 889 (2007); published online 12 April 2007 (10.1126/science.1141634)Neel J.V., (1976) The Genetics of Diabetes Mellitus, pp. 1-11. , W. Creutzfeldt, J. Köbberling, J. V. Neel, Eds, Springer, Berlin;
We thank the Finnish citizens who generously participated in this study; our colleagues from the DGI, WTCCC, and UKT2D for sharing prepublication data from their studies; S. Enloe of FUSION and E. Kwasnik, J. Gearhart, J. Romm, M. Zilka, C. Ongaco, A. Robinson, R. King, B. Craig, and E. Hsu of CIDR for expert technical work; and D. Leja of NHGRI for expert assistance with a figure. Support for this research was provided by NIH grants DK062370 (M.B, DK072193 (K.L.M, HL084729 (G.R.A, HG002651 (G.R.A, and U54 DA021519; National Human Genome Research Institute Intramural project number 1 Z01 HG000024 (F.S.C, a postdoctoral fellowship award from the American Diabetes Association (C.J.W, a Wenner-Gren Fellowship (L.P.O, and a Calvin Research Fellowship (R.P, Genome-wide genotyping was performed by the Johns Hopkins University Genetic Resources Core Facility (GRCF) SNP Center at CIDR with support from CIDR NIH (contract N01-HG-65403) and the GRCF SNP CenterUR - http://www.scopus.com/inward/record.url?eid=2-s2.0-34249885875&partnerID=40&md5=5258eca84c5e594411f46fe605d5e936
ER -
TI - Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
T2 - Nature Genetics
VL - 40
IS - 5
SP - 638
EP - 645
PY - 2008
AU - Zeggini E.
AU - Scott L.J.
AU - Saxena R.
AU - Voight B.F.
N1 - Export Date: 3 January 2016
N1 - References: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels (2007) Science, 316, pp. 1331-1336. , Diabetes Genetics Initiative;
Scott L.J., A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants (2007) Science, 316, pp. 1341-1345;
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (2007) Nature, 447, pp. 661-678. , Wellcome Trust Case Control Consortium;
Zeggini E., Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes (2007) Science, 316, pp. 1336-1341;
Steinthorsdottir V., A variant in CDKAL1 influences insulin response and risk of type 2 diabetes (2007) Nat. Genet, 39, pp. 770-775;
Sladek R., A genome-wide association study identifies novel risk loci for type 2 diabetes (2007) Nature, 445, pp. 881-885;
Florez J.C., A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: Replication and integration with other genome-wide datasets (2007) Diabetes, 56, pp. 3063-3074;
Rampersaud E., Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: Evidence for replication from diabetes-related quantitative traits and from independent populations (2007) Diabetes, 56, pp. 3053-3062;
Hanson R.L., A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array (2007) Diabetes, 56, pp. 3045-3052;
Hayes M.G., Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies (2007) Diabetes, 56, pp. 3033-3044;
Salonen J., Type 2 diabetes whole-genome association study in four populations: The DiaGen consortium (2007) Am. J. Hum. Genet, 81, pp. 338-345;
McCarthy M.I., Zeggini E., Genome-wide association scans for Type 2 diabetes: New insights into biology and therapy (2007) Trends Pharmacol. Sci, 28, pp. 598-601;
A second generation human haplotype map of over 3.1 million SNPs (2007) Nature, 449, pp. 851-861. , International HapMap Consortium;
Marchini J., Howie B., Myers S., McVean G., Donnelly P., A new multipoint method for genome-wide association studies by imputation of genotypes (2007) Nat. Genet, 39, pp. 906-913;
Freedman M.L., Assessing the impact of population stratification on genetic association studies (2004) Nat. Genet, 36, pp. 388-393;
Nakajima T., Fujino S., Nakanishi G., Kim Y.S., Jetten A.M., TIP27: A novel repressor of the nuclear orphan receptor TAK1/TR4 (2004) Nucleic Acids Res, 32, pp. 4194-4204;
Collins L.L., Growth retardation and abnormal maternal behavior in mice lacking testicular orphan nuclear receptor 4 (2004) Proc. Natl. Acad. Sci. USA, 101, pp. 15058-15063;
Thomas G., Multiple loci identified in a genome-wide association study of prostate cancer (2008) Nat. Genet, 40, pp. 310-315;
Gudmundsson J., Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes (2007) Nat. Genet, 39, pp. 977-983;
Winckler W., Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes (2007) Diabetes, 56, pp. 685-693;
Bieganowski P., Shilinski K., Tsichlis P.N., Brenner C., Cdc123 and checkpoint forkhead associated with RING proteins control the cell cycle by controlling eIF2γ abundance (2004) J. Biol. Chem, 273, pp. 44656-44666;
Drieschner N., Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin (2006) Thyroid, 16, pp. 1091-1096;
Drieschner N., A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas (2007) Gene, 403, pp. 110-117;
Lammert E., Brown J., Melton D.A., Notch gene expression during pancreatic organogenesis (2000) Mech. Dev, 94, pp. 199-203;
Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G., Measuring inconsistency in meta-analyses (2003) Br. Med. J, 327, pp. 557-560;
Risch N., Merikangas K., The future of genetic studies of complex human diseases (1996) Science, 273, pp. 1516-1517;
Lin S., Chakravarti A., Cutler D.J., Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies (2004) Nat. Genet, 36, pp. 1181-1188
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-42349106044&partnerID=40&md5=4a3d1501b51249b5d63b9f79a766a747
ER -
TI - Newly identified loci that influence lipid concentrations and risk of coronary artery disease
T2 - Nature Genetics
VL - 40
IS - 2
SP - 161
EP - 169
PY - 2008
AU - Willer C.J.
AU - Sanna S.
AU - Jackson A.U.
AU - Scuteri A.
AU - Bonnycastle L.L.
AU - Clarke R.
AU - Heath S.C.
AU - Timpson N.J.
AU - Najjar S.S.
AU - Stringham H.M.
AU - Strait J.
AU - Duren W.L.
AU - Maschio A.
AU - Busonero F.
AU - Mulas A.
AU - Albai G.
AU - Swift A.J.
AU - Morken M.A.
AU - Narisu N.
AU - Bennett D.
AU - Parish S.
AU - Shen H.
AU - Galan P.
AU - Meneton P.
AU - Hercberg S.
AU - Zelenika D.
AU - Chen W.-M.
AU - Li Y.
AU - Scott L.J.
AU - Scheet P.A.
AU - Sundvall J.
AU - Watanabe R.M.
AU - Nagaraja R.
AU - Ebrahim S.
AU - Lawlor D.A.
AU - Ben-Shlomo Y.
AU - Davey-Smith G.
AU - Shuldiner A.R.
AU - Collins R.
AU - Bergman R.N.
AU - Uda M.
AU - Tuomilehto J.
AU - Cao A.
AU - Collins F.S.
AU - Lakatta E.
AU - Lathrop G.M.
AU - Boehnke M.
AU - Schlessinger D.
AU - Mohlke K.L.
AU - Abecasis G.R.
N1 - Export Date: 3 January 2016
N1 - References: Mackay J., Mensah G.A., (2004) The Atlas of Heart Disease and Stroke, , World Health Organization, Geneva;
Law M.R., Wald N.J., Rudnicka A.R., Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis (2003) Br. Med. J, 326, p. 1423;
Kuulasmaa K., Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations (2000) Lancet, 355, pp. 675-687;
Clarke R., Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men (2007) Arch. Intern. Med, 167, pp. 1373-1378;
Grundy S.M., Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines (2004) Circulation, 110, pp. 227-239;
Gotto Jr. A.M., Brinton E.A., Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update (2004) J. Am. Coll. Cardiol, 43, pp. 717-724;
Blood cholesterol and vascular mortality by age, sex and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths (2007) Lancet, 370, pp. 1829-1839. , Prospective Studies Collaboration;
Bansal S., Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women (2007) J. Am. Med. Assoc, 298, pp. 309-316;
Nordestgaard B.G., Benn M., Schnohr P., Tybjaerg-Hansen A., Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women (2007) J. Am. Med. Assoc, 298, pp. 299-308;
Pilia G., Heritability of cardiovascular and personality traits in 6,148 Sardinians (2006) PLoS Genet, 2, pp. e132;
Pollin T.I., A genome-wide scan of serum lipid levels in the Old Order Amish (2004) Atherosclerosis, 173, pp. 89-96;
Breslow J.L., Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility (2000) Annu. Rev. Genet, 34, pp. 233-254;
Scott L.J., A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants (2007) Science, 316, pp. 1341-1345;
Scuteri A., Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity related traits (2007) PLoS Genet, 3, pp. e115;
Saxena R., Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels (2007) Science, 316, pp. 1331-1336;
Kathiresan S., (2008) Nat. Genet, , Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans, advance online publication 13 January, doi:10.1038/ng.75;
Chen W.M., Abecasis G.R., Family-based association tests for genome-wide association scans (2007) Am. J. Hum. Genet, 81, pp. 913-926;
Burdick J.T., Chen W.M., Abecasis G.R., Cheung V.G., In silico method for inferring genotypes in pedigrees (2006) Nat. Genet, 38, pp. 1002-1004;
The International HapMap Project (2005) Nature, 437, pp. 1299-1320. , The International HapMap Consortium;
George V.T., Elston R.C., Testing of association between polymorphic markers and quantitative traits in pedigrees (1987) Genet. Epidemiol, 4, pp. 193-201;
Abecasis G.R., Cardon L.R., Cookson W.O.C., A general test of association for quantitative traits in nuclear families (2000) Am. J. Hum. Genet, 66, pp. 279-292;
Devlin B., Roeder K., Genomic control for association studies (1999) Biometrics, 55, pp. 997-1004;
ISIS-3 Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet 339, 753-770 (1992)Keavney B., Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: Discrepancies between genotype, blood lipid concentrations, and coronary disease risk (2004) Int. J. Epidemiol, 33, pp. 1002-1013;
Post W., Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish (2007) Hum. Hered, 64, pp. 214-219;
Post W., Determinants of coronary artery and aortic calcification in the Old Order Amish (2007) Circulation, 115, pp. 717-724;
Hercberg S., The SU.VI.MAX Study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals (2004) Arch. Intern. Med, 164, pp. 2335-2342;
Hercberg S., A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: The SU.VI.MAX study-design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants (1998) Control. Clin. Trials, 19, pp. 336-351;
Caerphilly and Speedwell collaborative heart disease studies (1984) J. Epidemiol. Community Health, 38, pp. 259-262. , The Caerphilly and Speedwell Collaborative Group;
Bainton D., Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies (1992) Br. Heart J, 68, pp. 60-66;
Lawlor D.A., Bedford C., Taylor M., Ebrahim S., Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study (2003) J. Epidemiol. Community Health, 57, pp. 134-140;
Nielsen M.S., Jacobsen C., Olivecrona G., Gliemann J., Petersen C.M., Sortilin/ neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase (1999) J. Biol. Chem, 274, pp. 8832-8836;
Samani N.J., Genomewide association analysis of coronary artery disease (2007) N. Engl. J. Med, 357, pp. 443-453;
Koishi R., Angptl3 regulates lipid metabolism in mice (2002) Nat. Genet, 30, pp. 151-157;
Romeo S., Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL (2007) Nat. Genet, 39, pp. 513-516;
Murphy C., Murray A.M., Meaney S., Gafvels M., Regulation by SREBP-2 defines a potential link between isoprenoid and adenosylcobalamin metabolism (2007) Biochem. Biophys. Res. Commun, 355, pp. 359-364;
Kiss-Toth E., Human tribbles, a protein family controlling mitogen-activated protein kinase cascades (2004) J. Biol. Chem, 279, pp. 42703-42708;
Rauch U., Feng K., Zhou X.H., Neurocan: A brain chondroitin sulfate proteoglycan (2001) Cell. Mol. Life Sci, 58, pp. 1842-1856;
Kuivenhoven J.A., The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes (1997) J. Lipid Res, 38, pp. 191-205;
Pare G., Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol (2007) Am. J. Hum. Genet, 80, pp. 673-682;
Magrane J., Casaroli-Marano R.P., Reina M., Gafvels M., Vilaro S., The role of O-linked sugars in determining the very low density lipoprotein receptor stability or release from the cell (1999) FEBS Lett, 451, pp. 56-62;
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (2007) Nature, 447, pp. 661-678. , The Welcome Trust Case Control Consortium;
Helgadottir A., A common variant on chromosome 9p21 affects the risk of myocardial infarction (2007) Science, 316, pp. 1491-1493;
McPherson R., A common allele on chromosome 9 associated with coronary heart disease (2007) Science, 316, pp. 1488-1491;
Barzilai N., Unique lipoprotein phenotype and genotype associated with exceptional longevity (2003) J. Am. Med. Assoc, 290, pp. 2030-2040;
Baigent C., Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins (2005) Lancet, 366, pp. 1267-1278;
Cohen J.C., Multiple rare alleles contribute to low plasma levels of HDL cholesterol (2004) Science, 305, pp. 869-872;
Naoumova R.P., Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: Long-term follow-up and treatment response (2005) Arterioscler. Thromb. Vasc. Biol, 25, pp. 2654-2660;
Lind S., Autosomal recessive hypercholesterolaemia: Normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment (2004) J. Intern. Med, 256, pp. 406-412
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-38649125868&partnerID=40&md5=9e0dce72eed6e5266e9fe8cd17df756b
ER -
TI - Common variants at 30 loci contribute to polygenic dyslipidemia
T2 - Nature Genetics
VL - 41
IS - 1
SP - 56
EP - 65
PY - 2009
AU - Kathiresan S.
AU - Willer C.J.
AU - Peloso G.M.
AU - Demissie S.
AU - Musunuru K.
AU - Schadt E.E.
AU - Kaplan L.
AU - Bennett D.
AU - Li Y.
AU - Tanaka T.
AU - Voight B.F.
AU - Bonnycastle L.L.
AU - Jackson A.U.
AU - Crawford G.
AU - Surti A.
AU - Guiducci C.
AU - Burtt N.P.
AU - Parish S.
AU - Clarke R.
AU - Zelenika D.
AU - Kubalanza K.A.
AU - Morken M.A.
AU - Scott L.J.
AU - Stringham H.M.
AU - Galan P.
AU - Swift A.J.
AU - Kuusisto J.
AU - Bergman R.N.
AU - Sundvall J.
AU - Laakso M.
AU - Ferrucci L.
AU - Scheet P.
AU - Sanna S.
AU - Uda M.
AU - Yang Q.
AU - Lunetta K.L.
AU - Dupuis J.
AU - De Bakker P.I.W.
AU - O'Donnell C.J.
AU - Chambers J.C.
AU - Kooner J.S.
AU - Hercberg S.
AU - Meneton P.
AU - Lakatta E.G.
AU - Scuteri A.
AU - Schlessinger D.
AU - Tuomilehto J.
AU - Collins F.S.
AU - Groop L.
AU - Altshuler D.
AU - Collins R.
AU - Lathrop G.M.
AU - Melander O.
AU - Salomaa V.
AU - Peltonen L.
AU - Orho-Melander M.
AU - Ordovas J.M.
AU - Boehnke M.
AU - Abecasis G.R.
AU - Mohlke K.L.
AU - Cupples L.A.
N1 - Export Date: 3 January 2016
N1 - References: Manolio T.A., Brooks L.D., Collins F.S.A., HapMap harvest of insights into the genetics of common disease (2008) J. Clin. Invest, 118, pp. 1590-1605;
Lund University, and Novartis Institutes. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels (2007) Science, 316, pp. 1331-1336. , Diabetes Genetics Initiative of Broad Institute of Harvard and MIT;
Kathiresan S., Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans (2008) Nat. Genet, 40, pp. 189-197;
Willer C.J., Newly identified loci that influence lipid concentrations and risk of coronary artery disease (2008) Nat. Genet, 40, pp. 161-169;
Wallace C., Genome-wide association study identifies genes for biomarkers of cardiovascular disease: Serum urate and dyslipidemia (2008) Am. J. Hum. Genet, 82, pp. 139-149;
Sandhu M.S., LDL-cholesterol concentrations: A genome-wide association study (2008) Lancet, 371, pp. 483-491;
Kannel W.B., Dawber T.R., Kagan A., Revotskie N., Stokes III J., Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study (1961) Ann. Intern. Med, 55, pp. 33-50;
Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., Castelli W.P., An investigation of coronary heart disease in families. The Framingham offspring study (1979) Am. J. Epidemiol, 110, pp. 281-290;
Splansky G.L., The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: Design, recruitment, and initial examination (2007) Am. J. Epidemiol, 165, pp. 1328-1335;
Pe'er I., Yelensky R., Altshuler D., Daly M.J., Estimation of the multiple testing burden for genomewide association studies of nearly all common variants (2008) Genet. Epidemiol, 32, pp. 381-385;
Berglund G., Elmstahl S., Janzon L., Larsson S.A., The Malmo Diet and Cancer Study. Design and feasibility (1993) J. Intern. Med, 233, pp. 45-51;
Vartiainen E., Cardiovascular risk factor changes in Finland, 1972-1997 (2000) Int. J. Epidemiol, 29, pp. 49-56;
Scott L.J., A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants (2007) Science, 316, pp. 1341-1345;
ISIS-3. a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.. Lancet 339, 753-770 (1992)Kajinami K., Brousseau M.E., Nartsupha C., Ordovas J.M., Schaefer E.J., ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin (2004) J. Lipid Res, 45, pp. 653-656;
Romeo S., Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL (2007) Nat. Genet, 39, pp. 513-516;
Schaeffer L., Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids (2006) Hum. Mol. Genet, 15, pp. 1745-1756;
Ek J., The functional Thr130Ile and Val255Met polymorphisms of the hepatocyte nuclear factor-4alpha (HNF4A): Gene associations with type 2 diabetes or altered beta-cell function among Danes (2005) J. Clin. Endocrinol. Metab, 90, pp. 3054-3059;
Pare G., Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol (2007) Am. J. Hum. Genet, 80, pp. 673-682;
Spirin V., Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol (2007) Am. J. Hum. Genet, 81, pp. 1298-1303;
Hegele R.A., The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree (2000) Arterioscler. Thromb. Vasc. Biol, 20, pp. 217-222;
Schadt E.E., Mapping the genetic architecture of gene expression in human liver (2008) PLoS Biol, 6, pp. e107;
Jiang X., Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes (1996) J. Clin. Invest, 98, pp. 2373-2380;
Jiang X.C., Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels (1999) J. Clin. Invest, 103, pp. 907-914;
Isaacs A., Sayed-Tabatabaei F.A., Njajou O.T., Witteman J.C., van Duijn C.M., The - 514 C->T hepatic lipase promoter region polymorphism and plasma lipids: A meta-analysis (2004) J. Clin. Endocrinol. Metab, 89, pp. 3858-3863;
Phillipson B.E., Rothrock D.W., Connor W.E., Harris W.S., Illingworth D.R., Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia (1985) N. Engl. J. Med, 312, pp. 1210-1216;
Blatch G.L., Lassle M., The tetratricopeptide repeat: A structural motif mediating protein-protein interactions (1999) Bioessays, 21, pp. 932-939;
Berge K.E., Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters (2000) Science, 290, pp. 1771-1775;
Funke H., A molecular defect causing fish eye disease: An amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 4855-4859;
Buch S., A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease (2007) Nat. Genet, 39, pp. 995-999;
Odom D.T., Control of pancreas and liver gene expression by HNF transcription factors (2004) Science, 303, pp. 1378-1381;
Hayhurst G.P., Lee Y.H., Lambert G., Ward J.M., Gonzalez F.J., Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis (2001) Mol. Cell. Biol, 21, pp. 1393-1403;
Shih D.Q., Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism (2001) Nat. Genet, 27, pp. 375-382;
Yoshida K., Shimizugawa T., Ono M., Furukawa H., Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase (2002) J. Lipid Res, 43, pp. 1770-1772;
Toomey R.E., Wakil S.J., Studies on the mechanism of fatty acid synthesis. XVI. Preparation and general properties of acyl-malonyl acyl carrier protein-condensing enzyme from Escherichia coli (1966) J. Biol. Chem, 241, pp. 1159-1165;
Miyanishi M., Identification of Tim4 as a phosphatidylserine receptor (2007) Nature, 450, pp. 435-439;
Petersen H.H., Low-density lipoprotein receptor-related protein interacts with MafB, a regulator of hindbrain development (2004) FEBS Lett, 565, pp. 23-27;
Aalto-Setala K., Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles (1992) J. Clin. Invest, 90, pp. 1889-1900;
Luke M.M., A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease (2007) Arterioscler. Thromb. Vasc. Biol, 27, pp. 2030-2036;
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) JAMA, 285, pp. 2486-2497. , Executive summary of the third report of the National Cholesterol Education Program NCEP;
Cohen J., Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 (2005) Nat. Genet, 37, pp. 161-165;
Abifadel M., Mutations in PCSK9 cause autosomal dominant hypercholesterolemia (2003) Nat. Genet, 34, pp. 154-156;
Kotowski I.K., A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol (2006) Am. J. Hum. Genet, 78, pp. 410-422;
Maxwell K.N., Fisher E.A., Breslow J.L., Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment (2005) Proc. Natl. Acad. Sci. USA, 102, pp. 2069-2074;
Park S.W., Moon Y.A., Horton J.D., Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver (2004) J. Biol. Chem, 279, pp. 50630-50638;
Benjannet S., NARC-1/PCSK9 and its natural mutants: Zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol (2004) J. Biol. Chem, 279, pp. 48865-48875;
Cohen J.C., Boerwinkle E., Mosley Jr T.H., Hobbs H.H., Sequence variations in PCSK9, low LDL, and protection against coronary heart disease (2006) N. Engl. J. Med, 354, pp. 1264-1272;
Kathiresan S., Polymorphisms associated with cholesterol and risk of cardiovascular events (2008) N. Engl. J. Med, 358, pp. 1240-1249;
Kathiresan S., A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study (2007) BMC Med. Genet, 8 (SUPPL. 1), p. 17. , S;
Lange K., Boehnke M., Extensions to pedigree analysis. IV. Covariance components models for multivariate traits (1983) Am. J. Med. Genet, 14, pp. 513-524
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-58149163149&partnerID=40&md5=f9fe8cfea9a9b6d017fb8bbb7f3fb292
ER -
TI - A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
T2 - Nature Genetics
VL - 39
IS - 6
SP - 770
EP - 775
PY - 2007
AU - Steinthorsdottir V.
AU - Thorleifsson G.
AU - Reynisdottir I.
AU - Benediktsson R.
AU - Jonsdottir T.
AU - Walters G.B.
AU - Styrkarsdottir U.
AU - Gretarsdottir S.
AU - Emilsson V.
AU - Ghosh S.
AU - Baker A.
AU - Snorradottir S.
AU - Bjarnason H.
AU - Ng M.C.Y.
AU - Hansen T.
AU - Bagger Y.
AU - Wilensky R.L.
AU - Reilly M.P.
AU - Adeyemo A.
AU - Chen Y.
AU - Zhou J.
AU - Gudnason V.
AU - Chen G.
AU - Huang H.
AU - Lashley K.
AU - Doumatey A.
AU - So W.-Y.
AU - Ma R.C.Y.
AU - Andersen G.
AU - Borch-Johnsen K.
AU - Jorgensen T.
AU - Van Vliet-Ostaptchouk J.V.
AU - Hofker M.H.
AU - Wijmenga C.
AU - Christiansen C.
AU - Rader D.J.
AU - Rotimi C.
AU - Gurney M.
AU - Chan J.C.N.
AU - Pedersen O.
AU - Sigurdsson G.
AU - Gulcher J.R.
AU - Thorsteinsdottir U.
AU - Kong A.
AU - Stefansson K.
N1 - Export Date: 3 January 2016
N1 - References: Sladek R., A genome-wide association study identifies novel risk loci for type 2 diabetes (2007) Nature, 445, pp. 881-885;
Grant S.F., Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes (2006) Nat. Genet, 38, pp. 320-323;
Helgason A., Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution (2007) Nat. Genet, 39, pp. 218-225;
Pe'er I., Evaluating and improving power in whole-genome association studies using fixed marker sets (2006) Nat. Genet, 38, pp. 663-667;
Devlin B., Roeder K., Genomic control for association studies (1999) Biometrics, 55, pp. 997-1004;
Skol A.D., Scott L.J., Abecasis G.R., Boehnke M., Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies (2006) Nat. Genet, 38, pp. 209-213;
Chimienti F., Devergnas S., Favier A., Seve M., Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules (2004) Diabetes, 53, pp. 2330-2337;
Ching Y.P., Pang A.S., Lam W.H., Qi R.Z., Wang J.H., Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor (2002) J. Biol. Chem, 277, pp. 15237-15240;
Wei F.Y., Cdk5-dependent regulation of glucose-stimulated insulin secretion (2005) Nat. Med, 11, pp. 1104-1108;
Ubeda M., Rukstalis J.M., Habener J.F., Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity (2006) J. Biol. Chem, 281, pp. 28858-28864;
Reynisdottir I., Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2 (2003) Am. J. Hum. Genet, 73, pp. 323-335;
Tanko L.B., Bagger Y.Z., Nielsen S.B., Christiansen C., Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? (2003) Bone, 32, pp. 8-14;
Jorgensen T., A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: Baseline results Inter99 (2003) Eur. J. Cardiovasc. Prev. Rehabil, 10, pp. 377-386;
Helgadottir A., A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction (2006) Nat. Genet, 38, pp. 68-74;
Yang X., Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: The Hong Kong Diabetes Registry (2007) Diabetes Care, 30, pp. 65-70;
Rotimi C.N., In search of susceptibility genes for type 2 diabetes in West Africa: The design and results of the first phase of the AADM study (2001) Ann. Epidemiol, 11, pp. 51-58;
Kutyavin I.V., A novel endonuclease IV post-PCR genotyping system (2006) Nucleic Acids Res, 34, pp. e128;
Gretarsdottir S., The gene encoding phosphodiesterase 4D confers risk of ischemic stroke (2003) Nat. Genet, 35, pp. 131-138;
Rice J.A., (1995) Mathematical Statistics and Data Analysis, , Wadsworth, Belmont, California;
Mantel N., Haenszel W., Statistical aspects of the analysis of data from retrospective studies of disease (1959) J. Natl. Cancer Inst, 22, pp. 719-748;
Stefansson H., A common inversion under selection in Europeans (2005) Nat. Genet, 37, pp. 129-137;
Helgason A., Yngvadottir B., Hrafnkelsson B., Gulcher J., Stefansson K., An Icelandic example of the impact of population structure on association studies (2005) Nat. Genet, 37, pp. 90-95;
Sluiter W.J., Erkelens D.W., Reitsma W.D., Doorenbos H., Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading (1976) Diabetes, 25, pp. 241-244;
Hanson R.L., Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies (2000) Am. J. Epidemiol, 151, pp. 190-198;
Matthews D.R., Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man (1985) Diabetologia, 28, pp. 412-419;
A haplotype map of the human genome (2005) Nature, 437, pp. 1299-1320. , The International HapMap Consortium
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-34249828965&partnerID=40&md5=ffe22a6df77f2e7cf766c6f3823d7847
ER -
TI - Genome-wide association study identifies eight loci associated with blood pressure
T2 - Nature Genetics
VL - 41
IS - 6
SP - 666
EP - 676
PY - 2009
AU - Newton-Cheh C.
AU - Johnson T.
AU - Gateva V.
AU - Tobin M.D.
AU - Bochud M.
AU - Coin L.
AU - Najjar S.S.
AU - Zhao J.H.
AU - Heath S.C.
AU - Eyheramendy S.
AU - Papadakis K.
AU - Voight B.F.
AU - Scott L.J.
AU - Zhang F.
AU - Farrall M.
AU - Tanaka T.
AU - Wallace C.
AU - Chambers J.C.
AU - Khaw K.-T.
AU - Nilsson P.
AU - Van Der Harst P.
AU - Polidoro S.
AU - Grobbee D.E.
AU - Onland-Moret N.C.
AU - Bots M.L.
AU - Wain L.V.
AU - Elliott K.S.
AU - Teumer A.
AU - Luan J.
AU - Lucas G.
AU - Kuusisto J.
AU - Burton P.R.
AU - Hadley D.
AU - McArdle W.L.
AU - Brown M.
AU - Dominiczak A.
AU - Newhouse S.J.
AU - Samani N.J.
AU - Webster J.
AU - Zeggini E.
AU - Beckmann J.S.
AU - Bergmann S.
AU - Lim N.
AU - Song K.
AU - Vollenweider P.
AU - Waeber G.
AU - Waterworth D.M.
AU - Yuan X.
AU - Groop L.
AU - Orho-Melander M.
AU - Allione A.
AU - Di Gregorio A.
AU - Guarrera S.
AU - Panico S.
AU - Ricceri F.
AU - Romanazzi V.
AU - Sacerdote C.
AU - Vineis P.
AU - Barroso I.
AU - Sandhu M.S.
AU - Luben R.N.
AU - Crawford G.J.
AU - Jousilahti P.
AU - Perola M.
AU - Boehnke M.
AU - Bonnycastle L.L.
AU - Collins F.S.
AU - Jackson A.U.
AU - Mohlke K.L.
AU - Stringham H.M.
AU - Valle T.T.
AU - Willer C.J.
AU - Bergman R.N.
AU - Morken M.A.
AU - Döring A.
AU - Gieger C.
AU - Illig T.
AU - Meitinger T.
AU - Org E.
AU - Pfeufer A.
AU - Wichmann H.E.
AU - Kathiresan S.
AU - Marrugat J.
AU - O'Donnell C.J.
AU - Schwartz S.M.
AU - Siscovick D.S.
AU - Subirana I.
AU - Freimer N.B.
AU - Hartikainen A.-L.
AU - McCarthy M.I.
AU - O'Reilly P.F.
AU - Peltonen L.
AU - Pouta A.
AU - De Jong P.E.
AU - Snieder H.
AU - Van Gilst W.H.
AU - Clarke R.
AU - Goel A.
AU - Hamsten A.
AU - Altshuler D.
AU - Jarvelin M-R
AU - Elliott P.
AU - Lakatta E. G.
AU - Forouhi N.
AU - Wareham N. J.
AU - Loos R. J. F.
AU - Deloukas P.
AU - Bingham S. A.
AU - Zelenika D
AU - Strachan D. P.
AU - Soranzo N.
AU - Williams F. M.
AU - Zhai G.
AU - Spector T. D.
AU - Peden J. F.
AU - Watkins H.
AU - Ferrucci L.
AU - Caulfield M.
AU - Munroe P. B.
AU - Berglund G.
AU - Melander O.
AU - Matullo G.
AU - Uiterwaal C. S.
AU - van der Schouw Y. T.
AU - Numans M. E.
AU - Ernst F.
AU - Homuth G.
AU - Völker U.
AU - Eluosa R.
AU - Laakso M.
AU - Connell J. M.
AU - Mooser V.
AU - Salomaa V.
AU - Tuomilehto J.
AU - Laan M.
AU - Navis G.
AU - Seedorf U.
AU - Syvänen A-C
AU - Tognoni G.
AU - Sanna S.
AU - Uda M.
AU - Scheet P.
AU - Schlessinger D.
AU - Scuteri A.
AU - Dörr M.
AU - Felix S. B.
AU - Reffelmann T.
AU - Lorbeer R.
AU - Völzke H.
AU - Rettig R.
AU - Galan P.
AU - Hercberg S.
AU - Bingham S.A.
AU - Kooner J. S.
AU - Bandinelli S.
AU - Meneton P.
AU - Abecasis G.
AU - Thompson J. R.
AU - Braga Marcano C. A.
AU - Barke B.
AU - Dobson R.
AU - Gungadoo J.
AU - Lee K. L.
AU - Onipinla A.
AU - Wallace I.
AU - Xue M.
AU - Clayton D. G.
AU - Leung H-T
AU - Nutland S.
AU - Walker N. M.
AU - Todd J. A.
AU - Stevens H. E.
AU - Dunger D. B.
AU - Widmer B.
AU - Downes K.
AU - Cardon L. R.
AU - Kwiatkowski D. P.
AU - Barrett J. C.
AU - Evans D.
AU - Morris A. P.
AU - Lindgren C. M.
AU - Rayner N. W.
AU - Timpson N.
AU - Lyons E.
AU - Vannberg F.
AU - Hill A. V. S.
AU - Teo Y. Y.
AU - Rockett K. A.
AU - Craddock N.
AU - Attwood A. P.
AU - Bryan C.
AU - Bumpstead S. J.
AU - Chaney A.
AU - Ghori J.
AU - William R. G.
AU - Hunt S. E.
AU - Inouye M.
AU - Keniry E.
AU - King E.
AU - McGinnis R.
AU - Potter S.
AU - Ravindrarajan R.
AU - Whittaker P.
AU - Withers D.
AU - Bentley D.
AU - Groves C. J.
AU - Duncanson A.
AU - Ouwehand W. H.
AU - Boorman J. P.
AU - Cant B.
AU - Jolley J. D.
AU - Knight A. S.
AU - Koch K.
AU - Taylor N. C.
AU - Watkins N. A.
AU - Winzer T.
AU - Braund P. S.
AU - Dixon R. J.
AU - Mangino M.
AU - Stevens S.
AU - Donnely P.
AU - Davidson D.
AU - Marchini J. L.
AU - Spencer I. C. A.
AU - Cardin N. J.
AU - Ferreira T.
AU - Pereira-Gale J.
AU - Hallgrimsdottir I. B.
AU - Howie B. N.
AU - Su Z.
AU - Vukcevic D.
AU - Easton D.
AU - Everson U.
AU - Hussey J. M.
AU - Meech E.
AU - Prowse C. V.
AU - Walters G. R.
AU - Jones R. W.
AU - Ring S. M.
AU - Prembey M.
AU - Breen G.
AU - St. Clair D.
AU - Ceasar S.
AU - Gordon-Smith K.
AU - Jones L.
AU - Green E. K.
AU - Grozeva D.
AU - Hamshere M. L.
AU - Holmans P. A.
AU - Jones I. R.
AU - Kirov G.
AU - Moskovina V.
AU - Nikolov I.
AU - O'Donovan M. C.
AU - Owen M. J.
AU - Craddock N.
AU - Collier D. A.
AU - Elkin A.
AU - Farmer A.